Fresenius Medical Care AG (FMS) Equity Income (2010 - 2025)

Fresenius Medical Care AG's Equity Income history runs 16 years deep, the most recent figure standing at -$48.9 million for Q4 2025.

• In Q4 2025, Equity Income fell 42.97% year-over-year to -$48.9 million; the TTM figure through Dec 2025 stood at -$204.7 million (down 40.23% YoY), while the FY2025 annual figure was -$210.7 million, down 46.05% from the prior year.
• Equity Income was -$48.9 million for Q4 2025 at Fresenius Medical Care AG, up from -$54.6 million in the prior quarter.
• In the past five years, Equity Income ranged from a high of -$11.8 million in Q1 2022 to a low of -$54.6 million in Q3 2025.
• Historically, Equity Income has averaged -$33.0 million across 5 years, with a median of -$30.4 million in 2023.
• The sharpest annual moves came in 2021 and 2022: Equity Income slumped 515.97% in 2021, then jumped 64.85% in 2022.
• A 5-year view of Equity Income shows it stood at -$24.0 million in 2021, then climbed by 19.31% to -$19.4 million in 2022, then dropped by 27.66% to -$24.7 million in 2023, then sank by 38.18% to -$34.2 million in 2024, then plunged by 42.97% to -$48.9 million in 2025.
• The last three Equity Income figures came in at -$48.9 million (Q4 2025), -$54.6 million (Q3 2025), and -$50.9 million (Q2 2025), per Business Quant data.